Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Theresa is the lead Morning Rounds writer, and her stories focus on gender-affirming care, reproductive health, and mental health. You can reach Theresa on Signal at theresagaff.97. From 2021 to 2023, ...

A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the ...

In the months before killing her children, Lindsay Clancy repeatedly sought help for her deteriorating mental health.

AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. The biotech company Ultragenyx said ...

The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes Jennifer ...

Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance ...

An organ transplant first, new details on ADA conference controversy, and more health news from Morning Rounds ...

At a "practice of last resort," pediatricians prioritize allaying parents' vaccine concerns without hardline dismissals.

Ionis Pharmaceuticals on Thursday received Food and Drug Administration approval for the first disease modifying therapy for ...